Appendix 1. Author Relationships with Industry and Other Entities (Relevant) e115 Appendix 2. Reviewer Relationships with Industry and Other Entities (Comprehensive) e117 When developing ...

Although intravenous thrombolysis with alteplase remains the primary treatment for acute ischemic stroke, tenecteplase has shown potential advantages over alteplase. Animal studies have demonstrated ...

Circadian rhythms in physiology and behavior are ≈24-hour biological cycles regulated by internal biological clocks (ie, circadian clocks) that optimize organismal homeostasis in response to ...

Figure 1. Attendees of The First William Harvey Workshop on Endothelin (ET-1), chaired by Sir John Vane and held at St. Bartholomew’s Hospital, London, on December 6, 1988. This meeting marked the ...

In 1985 to 1986, the CARDIA (Coronary Artery Risk Development in Young Adults) study enrolled 5115 Black or White participants, including 2788 women, aged 18 to 30 years. Over the following 35 years, ...

From the Allegheny General Hospital, Pittsburgh, Pa (R.L.B.); ICON Clinical Research, San Francisco, Calif (D.P.M., A.J.F.); University of Chicago Medical Center ...

As early as 1699, Chemineau described a heart composed of 2 auricles but only 1 ventricle. 1 The univentricular heart has since fascinated the medical community. Unique in its complexity and scope, ...

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) ...

From Assistance Publique–Hôpitaux de Paris, Department of Cardiovascular Medicine (P.L.), INSERM U841, Henri Mondor Hospital, Creteil, France; and Department of ...

From the Centro Cuore Columbus (I.M., C. Di M., B.R., L. Di F., G.M., A.C.), Milan, Italy; Lenox Hill Hospital (J.M.), New York, NY; and the Department of Cardiology ...

Hypertension is the leading risk factor for cardiovascular disease worldwide. Patients with blood pressure (BP) response to dietary sodium reduction are referred to as “salt sensitive.” Salt ...

Background— Clinical trials in ischemic patients showed the safety and benefit of autologous bone marrow progenitor cell transplantation. Non–bone marrow progenitor cells with proangiogenic capacitie ...